Product Information
FUROSEMIDE 20 MG/2 ML VIAL is a generic product labeled by Sagent Pharmaceuticals, priced at $0.4901 per ML under NDC 25021032002. Its NADAC has been published 46 times since Nov 19, 2025.
FDA first approved this application on Jan 27, 2021. Its Orange Book therapeutic-equivalence code is AP.
Strength
10 mg/mL
Manufacturer
Sagent PharmaceuticalsNDC
25021032002
Classification
Generic
Dosage Form
INJECTION, SOLUTION
Route
INTRAMUSCULAR; INTRAVENOUS
Effective Date
9/23/2026
Active Ingredients
FUROSEMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA214766FDA Approved
1/27/2021
TE Code
AP
On Market Since
7/15/2025
Pharmacological Classes
Price Statistics
The NADAC for FUROSEMIDE 20 MG/2 ML VIAL has been published 46 times since Nov 19, 2025, and over the history we have for it it has risen 40.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4901 per ML |
|---|---|
| All-time high | $0.4901 (Sep 30, 2026) |
| All-time low | $0.3473 (Dec 17, 2025) |
| 52-week high | $0.4901 |
| 52-week low | $0.3473 |
| Median price | $0.4049 |
| Average price | $0.4007 |
| Largest weekly change | +7.6% (Mar 18, 2026) |
| Weeks tracked | 46 |
| Tracking since | Nov 19, 2025 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 48% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Sagent Pharmaceuticals manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Furosemide market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Loop Diuretic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FUROSEMIDE 20 MG/2 ML VIAL?
The current National Average Drug Acquisition Cost (NADAC) for FUROSEMIDE 20 MG/2 ML VIAL, manufactured by Sagent Pharmaceuticals, is $0.4901 per ML (NDC 25021032002), effective Sep 30, 2026.
How has the price of FUROSEMIDE 20 MG/2 ML VIAL changed over time?
Over the history we have for it, the NADAC for FUROSEMIDE 20 MG/2 ML VIAL has risen 40.0%. It has been tracked across 46 weekly CMS publications since Nov 19, 2025.
What are the highest and lowest recorded NADAC prices for FUROSEMIDE 20 MG/2 ML VIAL?
Since Nov 19, 2025, the NADAC for FUROSEMIDE 20 MG/2 ML VIAL has ranged from a low of $0.3473 (Dec 17, 2025) to a high of $0.4901 (Sep 30, 2026), with a median of $0.4049 per ML.
Are there cheaper alternatives to FUROSEMIDE 20 MG/2 ML VIAL?
Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, FUROSEMIDE 40 MG/4 ML VIAL, is $0.2525 per ML — about 48% below FUROSEMIDE 20 MG/2 ML VIAL.
Who manufactures FUROSEMIDE 20 MG/2 ML VIAL?
FUROSEMIDE 20 MG/2 ML VIAL (NDC 25021032002) is labeled by Sagent Pharmaceuticals, and CMS classifies it as a generic product.